AI could revolutionize cancer diagnosis in new study
NCT ID NCT07269236
First seen Dec 12, 2025 · Last updated May 24, 2026 · Updated 26 times
Summary
This study is testing a new artificial intelligence (AI) tool that looks at medical images, lab results, and patient information to help doctors better diagnose and treat cancer. The goal is to see if the AI can accurately classify tumors, predict treatment responses, and support personalized care. About 2,000 adults with various cancers will participate, and their data will be used to train and evaluate the AI model.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, 510515, China
-
Zhongshan City People's Hospital
Zhongshan, Guangdong, 513000, China
Conditions
Explore the condition pages connected to this study.